Brown-Forman (BF) holder plans $1.32M Rule 144 sale of Class A stock
Rhea-AI Filing Summary
Brown-Forman insider plans to sell Class A shares under Rule 144. A holder has filed notice to sell 42,495 shares of Class A Common Stock of Brown-Forman, to be handled through Raymond James & Associates on the NYSE. The filing lists an aggregate market value of $1,317,345.00 for the planned sale and notes that 169,143,808 shares of this class were outstanding at the time referenced.
The shares to be sold were acquired over several years as equity compensation in the form of restricted stock units or performance-based restricted stock units granted by the issuer between 2017 and 2024. The seller also represents that they do not know of any material adverse, nonpublic information about Brown-Forman’s current or prospective operations.
Positive
- None.
Negative
- None.
FAQ
What does Brown-Forman (BF) report in this Form 144 filing?
The filing reports that a holder intends to sell 42,495 shares of Class A Common Stock of Brown-Forman under Rule 144, through Raymond James & Associates on the NYSE, with an indicated aggregate market value of $1,317,345.00.
How many Brown-Forman (BF) Class A shares are outstanding in this notice?
The notice states that there are 169,143,808 Class A Common Stock shares outstanding for Brown-Forman as of the referenced time in the filing.
How were the Brown-Forman (BF) shares being sold under Rule 144 acquired?
The shares were acquired over multiple years as equity compensation in the form of RSUs or PBRSUs, granted by the issuer on dates including 06/03/2024, 06/01/2023, 06/01/2022, 06/01/2021, 06/01/2020, 06/03/2019, 04/30/2019, and 04/30/2017, with the nature of payment listed as Compensation.
Which broker and exchange are involved in the planned sale of Brown-Forman (BF) shares?
The Form 144 lists Raymond James & Associates, located at 880 Carillon Parkway, St. Petersburg, FL 33716, as the broker, and names the NYSE as the securities exchange for the sale of the Class A Common Stock.
What representation does the seller of Brown-Forman (BF) shares make in this Form 144?
The person for whose account the securities are to be sold represents that they do not know any material adverse information about Brown-Forman’s current or prospective operations that has not been publicly disclosed. If relying on a Rule 10b5-1 plan, this representation applies as of the plan adoption or instruction date.
Is the planned sale in Brown-Forman (BF) Form 144 related to a Rule 10b5-1 trading plan?
The form provides a field for the Date of Plan Adoption or Giving of Instruction, if relying on Rule 10b5-1. The excerpt shows this field but does not provide a specific date, while reiterating the standard representation regarding lack of undisclosed material adverse information.